News Overview

Avanti Feeds Limited has informed the Exchange about Credit Rating

Venus Remedies Limited with respect to announcement dated 30-Dec-2021, regarding appointment of Dr. Savita Gupta as Additional Director (Non- Executive Independent Director) of the company. On basis of above the Company was required to clarify following - 1. Confirmation in compliance with SEBI Letter dated June 14, 2018 read alongwith NSE Circular dated June 20, 2018. The response of the Company is attached.

Royal Orchid Hotels Limited with respect to announcement dated 12-Feb-2022, regarding the proposal to provide security towards loan of Subsidiary Company, Maruti Comforts & Inn Private Limited. On basis of above the Company was required to clarify following: 1. Name of party for which such guarantees or indemnity or surety was given; 2. Whether the promoter/ promoter group/ group companies have any interest in this transaction? If yes, nature of interest and details thereof and whether the same is done at arms length; 3. Brief details of such guarantee or indemnity or becoming a surety viz. brief details of agreement entered (if any) including significant terms and conditions, including amount of guarantee; The response of the Company is attached.

E2E Networks Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

Welspun Enterprises has allotted 769000 equity shares under ESOP on 12 February 2022 Consequently the equity share capital has increased to 149783056 aggregating Rs 14978 crore

Glenmark Pharmaceuticals today announced that its subsidiary Glenmark Pharmaceuticals Colombia SAS and Astrazeneca Colombia SAS have entered into an exclusive licensing agreement for the commercialization of Astrazenecas drug Pulmicort Respules Under the terms of the agreement Astrazeneca remains the holder of the registration for Pulmicort Respules and will be responsible for manufacturing and supplying the drug Glenmark will be responsible for commercialization of Pulmicort Respules […]

Zydus US subsidiary Zydus Pharmaceuticals USA Inc has received final approval from the USFDA to market Roflumilast Tablets in the strength of 500 mcg and a tentative approval for Roflumilast Tablets 250 mcg US RLD – DALIRESP Zydus being one of the first applicants for Roflumilast Tablets 500 mcg is eligible for 180 days of shared generic drug exclusivity under section 505j5Biv of the FDC […]

Hindalco Industries has allotted 1192 equity shares under ESOS on 14 February 2022

GAIL India announced that Deepak Gupta has assumed charge as Director Projects of the company GAIL is implementing the expansion of its pipeline network by over 5600 km at an investment of over Rs 25000 crore in the next few years GAIL owns cross country network of natural gas pipeline operations for nearly 14000 km GAIL owns and operates over 2000 km network of LPG […]

Tide Water Oil Company India announced that the Board of Directors of the Company at its meeting held on 14 February 2022 has recommended a Second Interim dividend of Rs20 per share ie1000Percentage subject to the approval of the shareholders